USD 70.96
(-2.94%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -7.6 Million USD | 127.01% |
2022 | -28.96 Million USD | 19.52% |
2021 | -38.48 Million USD | -62.97% |
2020 | -23.15 Million USD | 14.17% |
2019 | -27.93 Million USD | -46.4% |
2018 | -20.22 Million USD | -2.25% |
2017 | -19.08 Million USD | 14.66% |
2016 | -22.66 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 17.1 Million USD | 1.69% |
2024 Q1 | 16.82 Million USD | 50.57% |
2024 Q3 | 8.52 Million USD | -23.78% |
2023 Q3 | -23.33 Million USD | -1630.43% |
2023 Q4 | 6.3 Million USD | 127.03% |
2023 Q1 | -1.53 Million USD | 73.06% |
2023 Q2 | 1.52 Million USD | 199.41% |
2023 FY | - USD | 127.01% |
2022 Q1 | -9.08 Million USD | 22.14% |
2022 FY | - USD | 19.52% |
2022 Q4 | -5.69 Million USD | 0.61% |
2022 Q3 | -5.72 Million USD | 41.14% |
2022 Q2 | -9.73 Million USD | -7.1% |
2021 Q2 | -9.24 Million USD | -32.83% |
2021 Q1 | -6.96 Million USD | -30.6% |
2021 FY | - USD | -62.97% |
2021 Q4 | -11.67 Million USD | -1.34% |
2021 Q3 | -11.51 Million USD | -24.58% |
2020 Q3 | -4.11 Million USD | 45.11% |
2020 Q1 | -7.42 Million USD | 8.33% |
2020 FY | - USD | 14.17% |
2020 Q4 | -5.33 Million USD | -29.65% |
2020 Q2 | -7.49 Million USD | -0.82% |
2019 Q4 | -8.1 Million USD | -12.77% |
2019 Q2 | -7.16 Million USD | -18.2% |
2019 Q1 | -6.06 Million USD | 2.22% |
2019 FY | - USD | -46.4% |
2019 Q3 | -7.18 Million USD | -0.24% |
2018 Q3 | -3.62 Million USD | 33.03% |
2018 Q2 | -5.41 Million USD | -21.91% |
2018 Q1 | -4.44 Million USD | -2.37% |
2018 Q4 | -6.2 Million USD | -71.12% |
2018 FY | - USD | -2.25% |
2017 Q3 | -4.55 Million USD | 18.23% |
2017 FY | - USD | 14.66% |
2017 Q2 | -5.56 Million USD | -2.14% |
2017 Q1 | -5.45 Million USD | 0.0% |
2017 Q4 | -4.33 Million USD | 4.77% |
2016 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acutus Medical, Inc. | -13.48 Million USD | 43.627% |
Cerus Corporation | -26.53 Million USD | 71.348% |
OrthoPediatrics Corp. | -8.38 Million USD | 9.283% |
PetVivo Holdings, Inc. | -10.49 Million USD | 27.552% |
Talis Biomedical Corporation | -66.04 Million USD | 88.488% |
Vivos Therapeutics, Inc. | -16.67 Million USD | 54.405% |
Inogen, Inc. | -45.67 Million USD | 83.356% |
Spectral AI, Inc. | -12.26 Million USD | 37.995% |
Nano-X Imaging Ltd. | -47.69 Million USD | 84.058% |
CVRx, Inc. | -38.73 Million USD | 80.37% |
DIH Holding US, Inc. Warrants | -3.52 Million USD | -115.505% |
Helius Medical Technologies, Inc. | -12.1 Million USD | 37.202% |
Orthofix Medical Inc. | -86.98 Million USD | 91.259% |
Venus Concept Inc. | -26.11 Million USD | 70.884% |
Accelerate Diagnostics, Inc. | -49.77 Million USD | 84.724% |
Bioventus Inc. | -23.07 Million USD | 67.044% |
BrainsWay Ltd. | -2.31 Million USD | -228.992% |
Envoy Medical, Inc. | -18.23 Million USD | 58.312% |
electroCore, Inc. | -17.76 Million USD | 57.19% |
IceCure Medical Ltd | -15.25 Million USD | 50.154% |
Lucid Diagnostics Inc. | -49.75 Million USD | 84.718% |
Monogram Orthopaedics, Inc. | -16.85 Million USD | 54.894% |
MaxCyte, Inc. | -44.12 Million USD | 82.771% |
NeuroOne Medical Technologies Corporation | -11.75 Million USD | 35.327% |
Nexalin Technology, Inc. | -5.69 Million USD | -33.572% |
PAVmed Inc | -75.74 Million USD | 89.962% |
Rapid Micro Biosystems, Inc. | -53.75 Million USD | 85.857% |
RxSight, Inc. | -41.03 Million USD | 81.473% |
Sight Sciences, Inc. | -49.41 Million USD | 84.614% |
SI-BONE, Inc. | -34.44 Million USD | 77.928% |
TELA Bio, Inc. | -40.63 Million USD | 81.289% |
TriSalus Life Sciences, Inc. | -58.29 Million USD | 86.958% |
Treace Medical Concepts, Inc. | -39 Million USD | 80.509% |
LivaNova PLC | 39.01 Million USD | 119.487% |
908 Devices Inc. | -34.02 Million USD | 77.655% |
Alphatec Holdings, Inc. | -110.59 Million USD | 93.125% |
Nemaura Medical Inc. | -7.28 Million USD | -4.336% |
NeuroPace, Inc. | -22.83 Million USD | 66.703% |
LENSAR, Inc. | -8.71 Million USD | 12.75% |
Apyx Medical Corporation | -18.11 Million USD | 58.022% |
Cutera, Inc. | -136.56 Million USD | 94.433% |
STRATA Skin Sciences, Inc. | -3.38 Million USD | -124.941% |
BioSig Technologies, Inc. | -28.15 Million USD | 72.992% |
Anika Therapeutics, Inc. | 2.51 Million USD | 402.186% |
ClearPoint Neuro, Inc. | -20.98 Million USD | 63.776% |
Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.982% |
Axonics, Inc. | 7.77 Million USD | 197.788% |
Outset Medical, Inc. | -153.78 Million USD | 95.056% |
IRIDEX Corporation | -7.44 Million USD | -2.081% |
PROCEPT BioRobotics Corporation | -98.09 Million USD | 92.249% |
IRadimed Corporation | 20.8 Million USD | 136.552% |
Tivic Health Systems, Inc. | -8.06 Million USD | 5.693% |
INVO Bioscience, Inc. | -6.88 Million USD | -10.508% |
Telesis Bio, Inc. | -40.49 Million USD | 81.224% |
Viemed Healthcare, Inc. | 36.67 Million USD | 120.73% |
Varex Imaging Corporation | 67.2 Million USD | 111.314% |
Quipt Home Medical Corp. | 44.07 Million USD | 117.252% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 30.055% |
Pulmonx Corporation | -55.09 Million USD | 86.199% |
Dynatronics Corporation | -976 Thousand USD | -678.99% |
Modular Medical, Inc. | -17.1 Million USD | 55.546% |
ReShape Lifesciences Inc. | -14.48 Million USD | 47.511% |
Semler Scientific, Inc. | 23.58 Million USD | 132.231% |
InMode Ltd. | 196.28 Million USD | 103.873% |
Bruker Corporation | 599 Million USD | 101.269% |
Cytosorbents Corporation | -28.81 Million USD | 73.611% |
DexCom, Inc. | 916.7 Million USD | 100.829% |
Align Technology, Inc. | 799.03 Million USD | 100.952% |
Viveve Medical, Inc. | -20.61 Million USD | 63.123% |
ZimVie Inc. | 91.07 Million USD | 108.348% |
Movano Inc. | -29.12 Million USD | 73.895% |
Cytek Biosciences, Inc. | -4.4 Million USD | -72.482% |
Nexalin Technology, Inc. | -5.69 Million USD | -33.572% |
DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -115.505% |
Tandem Diabetes Care, Inc. | -194.65 Million USD | 96.094% |
Profound Medical Corp. | -27.12 Million USD | 71.969% |
Insulet Corporation | 323.6 Million USD | 102.35% |
enVVeno Medical Corporation | -25.01 Million USD | 69.61% |
Surmodics, Inc. | 1.18 Million USD | 739.983% |
iCAD, Inc. | -6.56 Million USD | -15.811% |
Nuwellis, Inc. | -16.35 Million USD | 53.516% |
Biotricity, Inc. | -8.82 Million USD | 13.879% |
iRhythm Technologies, Inc. | -96.86 Million USD | 92.151% |
Aethlon Medical, Inc. | -11.84 Million USD | 35.835% |
InspireMD, Inc. | -20.91 Million USD | 63.641% |
PAVmed Inc. | -75.74 Million USD | 89.962% |
BIOLASE, Inc. | -15.13 Million USD | 49.779% |
Beyond Air, Inc. | -59.03 Million USD | 87.12% |
FONAR Corporation | 28.25 Million USD | 126.912% |
AxoGen, Inc. | -13.32 Million USD | 42.955% |
Vivani Medical, Inc. | -26.6 Million USD | 71.426% |
Tactile Systems Technology, Inc. | 24.54 Million USD | 130.981% |
Inari Medical, Inc. | 7.11 Million USD | 206.889% |
UFP Technologies, Inc. | 72.74 Million USD | 110.452% |
QT Imaging Holdings, Inc. | -3.38 Million USD | -124.556% |
Heart Test Laboratories, Inc. | -6.15 Million USD | -23.506% |
Tenon Medical, Inc. | -15.52 Million USD | 51.037% |
Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 50.197% |
Co-Diagnostics, Inc. | -41.47 Million USD | 81.669% |
AdaptHealth Corp. | -171.09 Million USD | 95.556% |
Sintx Technologies, Inc. | -6.6 Million USD | -15.197% |
NanoVibronix, Inc. | -3.43 Million USD | -121.339% |
Quanterix Corporation | -38.08 Million USD | 80.038% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 30.055% |
Sensus Healthcare, Inc. | 30 Thousand USD | 25443.333% |
Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.258% |
ReWalk Robotics Ltd. | -21.76 Million USD | 65.068% |
NeuroMetrix, Inc. | -7.09 Million USD | -7.148% |
Hyperfine, Inc. | -47.06 Million USD | 83.844% |
Establishment Labs Holdings Inc. | -58.3 Million USD | 86.96% |
Biomerica, Inc. | -5.99 Million USD | -26.865% |
Bone Biologics Corporation | 479.57 Thousand USD | 1685.372% |
AVITA Medical, Inc. | -39.56 Million USD | 80.785% |
Bluejay Diagnostics, Inc. | -9.17 Million USD | 17.115% |
Silk Road Medical, Inc | -45.08 Million USD | 83.134% |